The Zhitong Finance App learned that CRO concept stocks declined across the board, and individual Pharmaceutical stocks once again led the decline. As of press release, Pharmaceuticals (02359) fell 4.56% to HK$42.9; Zhaoyan New Pharmaceutical (06127) fell 4.37% to HK$10.06; Tiger Pharmaceuticals (03347) fell 1.63% to HK$33.1; Gloria Ying (06821) fell 0.97% to HK$71.1; furthermore, Pharmaceuticals (02268) fell 4.07% to HK$15.04.
According to the news, on the evening of March 13, Bio announced that it would cancel the WUXi (Medicinal Kangde) membership and end its cooperation with it. In a press release, Bio said it will take steps to “eliminate Medicinal Kangde membership” and fully support the US Biosafety Act.
Furthermore, according to the latest news, BIO revised and updated the content of a press release it issued on the 13th on March 14, US time: “BIO is currently taking measures to remove Pharmacom Kangde's membership in the organization” before the revision has been revised to “Pharmacom Kangde voluntarily terminates its BIO membership.”